microdosing glp-1 menopause Can GLP 1 Enhance Fat Loss During the Fitness Definition Phase? GLP-1 Medications, Menopause, and Metabolic

doi: 10.1172/jci155333, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 64

Its obesity-related effects are well-documented and are slightly better than those for drugs already on the market, such as Ozempic, Zepbound, Mounjaro, and a few others

Fear of patient spillover from one indication to another has increased payer control with prior authorization requirements being used as a primary obstacle to access

Already, the impact is being felt, as Walmart attested in their latest earnings call: This article will hopefully serve as a primer for not just GLP-1s, but a springboard for a discussion on potential secondary knock-on effects in both patients taking them and the wider economy